다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

IRON

Disc Medicine (IRON)

Disc Medicine Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IRON

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/09	21:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IRON	Disc Medicine Inc
2024/05/09	21:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
2024/05/09	21:00	GlobeNewswire Inc.	Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:IRON	Disc Medicine Inc
2024/04/01	21:00	GlobeNewswire Inc.	Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)	NASDAQ:IRON	Disc Medicine Inc
2024/03/21	21:00	GlobeNewswire Inc.	Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:IRON	Disc Medicine Inc
2024/03/07	06:30	GlobeNewswire Inc.	Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024	NASDAQ:IRON	Disc Medicine Inc
2024/03/02	09:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2024/03/02	09:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2024/03/02	09:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2024/03/02	09:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2024/02/26	22:43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
2024/02/26	22:30	GlobeNewswire Inc.	Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer	NASDAQ:IRON	Disc Medicine Inc
2024/02/20	22:30	GlobeNewswire Inc.	Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease	NASDAQ:IRON	Disc Medicine Inc
2024/02/16	06:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2024/02/14	08:51	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IRON	Disc Medicine Inc
2024/02/09	23:00	GlobeNewswire Inc.	Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera	NASDAQ:IRON	Disc Medicine Inc
2024/02/07	22:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
2024/02/07	22:00	GlobeNewswire Inc.	Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer	NASDAQ:IRON	Disc Medicine Inc
2024/02/07	06:55	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2024/01/24	07:48	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2024/01/05	06:24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2024/01/04	07:00	GlobeNewswire Inc.	Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:IRON	Disc Medicine Inc
2024/01/04	06:18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2024/01/03	06:30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2023/12/30	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2023/12/21	06:30	GlobeNewswire Inc.	Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board	NASDAQ:IRON	Disc Medicine Inc
2023/12/15	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2023/12/13	06:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2023/12/12	10:30	GlobeNewswire Inc.	Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual Meeting	NASDAQ:IRON	Disc Medicine Inc
2023/12/12	02:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc

검색 관련기사 보기:NASDAQ:IRON

1 2 3 4 5 다음 >>

US Dollar vs Sterling

US Dollar vs Euro

Invesco QQQ Trust Series 1

BNP Paribas (QX)

US Dollar vs Yen

Health Care Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관